JoVE Logo

Entrar

5.11 : Phase II Reactions: Acetylation Reactions

Acetylation, a phase II biotransformation reaction, introduces an acetyl group to drugs or their metabolites. Acetyltransferase enzymes facilitate this reaction, which resembles α-amino acid conjugation due to the addition of a functional group to the drug molecule.

The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and aromatic amines. Notable drugs that undergo this process include isoniazid, procainamide, sulfonamides, neurotransmitters like catecholamines, and hormones.

Acetylation has crucial implications for drug toxicity. In certain situations, acetylation can lead to the creation of toxic metabolites. For instance, the acetylation of isoniazid can result in a tissue acylating intermediate that may cause liver toxicity. Furthermore, genetic variations known as acetylation polymorphisms can impact drug metabolism and response. These variations affect the enzymes responsible for acetylation, leading to individuals being either fast or slow acetylators. This distinction results in varied drug efficacy and toxicity levels.

Tags

AcetylationPhase II BiotransformationAcetyltransferase EnzymesDrug MetabolitesAmino GroupSulfonamideHydrazinePrimary AminesSecondary AminesAromatic AminesDrug ToxicityToxic MetabolitesAcetylation PolymorphismsDrug MetabolismFast AcetylatorsSlow Acetylators

Do Capítulo 5:

article

Now Playing

5.11 : Phase II Reactions: Acetylation Reactions

Pharmacokinetics: Drug Biotransformation

175 Visualizações

article

5.1 : Drug Biotransformation: Overview

Pharmacokinetics: Drug Biotransformation

341 Visualizações

article

5.2 : Phase I Oxidative Reactions: Overview

Pharmacokinetics: Drug Biotransformation

233 Visualizações

article

5.3 : Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

Pharmacokinetics: Drug Biotransformation

142 Visualizações

article

5.4 : Phase I Reactions: Oxidation of Carbon-Heteroatom and Miscellaneous Systems

Pharmacokinetics: Drug Biotransformation

63 Visualizações

article

5.5 : Phase I Reactions: Reductive Reactions

Pharmacokinetics: Drug Biotransformation

174 Visualizações

article

5.6 : Phase I Reactions: Hydrolytic Reactions

Pharmacokinetics: Drug Biotransformation

73 Visualizações

article

5.7 : Phase II Conjugation Reactions: Overview

Pharmacokinetics: Drug Biotransformation

156 Visualizações

article

5.8 : Phase II Reactions: Glucuronidation

Pharmacokinetics: Drug Biotransformation

273 Visualizações

article

5.9 : Phase II Reactions: Sulfation and Conjugation with α-Amino Acids

Pharmacokinetics: Drug Biotransformation

167 Visualizações

article

5.10 : Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Pharmacokinetics: Drug Biotransformation

141 Visualizações

article

5.12 : Phase II Reactions: Methylation Reactions

Pharmacokinetics: Drug Biotransformation

132 Visualizações

article

5.13 : Phase II Reactions: Miscellaneous Conjugation Reactions

Pharmacokinetics: Drug Biotransformation

39 Visualizações

article

5.14 : Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs

Pharmacokinetics: Drug Biotransformation

183 Visualizações

article

5.15 : Factors Affecting Drug Biotransformation: Biological

Pharmacokinetics: Drug Biotransformation

107 Visualizações

JoVE Logo

Privacidade

Termos de uso

Políticas

Pesquisa

Educação

SOBRE A JoVE

Copyright © 2025 MyJoVE Corporation. Todos os direitos reservados